| Human T-bet governs innate and innate-like adaptive IFN-γ immunity against mycobacteria R Yang, F Mele, L Worley, D Langlais, J Rosain, I Benhsaien, H Elarabi, ... Cell 183 (7), 1826-1847. e31, 2020 | 115 | 2020 |
| Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer S Singh, N Lee, DA Pedroza, IL Bado, C Hamor, L Zhang, S Aguirre, J Hu, ... Cancer research 82 (12), 2281-2297, 2022 | 41 | 2022 |
| EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer X Wang, T Semba, GC Manyam, J Wang, S Shao, F Bertucci, P Finetti, ... Science Advances 8 (50), eabn7983, 2022 | 31 | 2022 |
| A novel immunomodulatory 27-gene signature to predict response to neoadjuvant immunochemotherapy for primary triple-negative breast cancer T Iwase, KRM Blenman, X Li, E Reisenbichler, R Seitz, D Hout, TJ Nielsen, ... Cancers 13 (19), 4839, 2021 | 26 | 2021 |
| Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer O Adewunmi, Y Shen, XHF Zhang, JM Rosen Cancer immunology research 11 (11), 1462-1479, 2023 | 22 | 2023 |
| Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal X Hao, Y Shen, N Chen, W Zhang, E Valverde, L Wu, HL Chan, Z Xu, L Yu, ... Cell stem cell 30 (5), 648-664. e8, 2023 | 20 | 2023 |
| Association of regular glucosamine use with incident dementia: evidence from a longitudinal cohort and Mendelian randomization study J Zheng, C Ni, Y Zhang, J Huang, DN Hukportie, B Liang, S Tang BMC medicine 21 (1), 114, 2023 | 16* | 2023 |
| Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells W Zhang, Z Xu, X Hao, T He, J Li, Y Shen, K Liu, Y Gao, J Liu, ... Cancer discovery 13 (2), 474-495, 2023 | 16 | 2023 |
| Thymic-specific regulation of TCR signaling by Tespa1 J Lyu, P Wang, T Xu, Y Shen, Z Cui, M Zheng, G Fu, L Lu Cellular & molecular immunology 16 (12), 897-907, 2019 | 11 | 2019 |
| Optimization and characterization of a bone culture model to study prostate cancer bone metastasis YH Wu, Z Gugala, MM Barry, Y Shen, S Dasgupta, H Wang Molecular cancer therapeutics 21 (8), 1360-1368, 2022 | 6 | 2022 |
| Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer. T Iwase, L Pusztai, K Blenman, X Li, R Seitz, TJ Nielsen, BL Schweitzer, ... Journal of Clinical Oncology 38 (15_suppl), 3117-3117, 2020 | 3 | 2020 |
| Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development X Wang, T Semba, GC Manyam, J Wang, S Shao, F Bertucci, P Finetti, ... CANCER RESEARCH 82 (4), 2022 | 1 | 2022 |
| Abstract PD10-08: Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development X Wang, T Semba, GC Manyam, J Wang, S Shao, F Bertucci, P Finetti, ... Cancer Research 82 (4_Supplement), PD10-08-PD10-08, 2022 | 1 | 2022 |
| Solid tumour-induced systemic immunosuppression involves dichotomous myeloid–B cell interactions X Hao, Y Shen, J Liu, A Alexander, L Wu, Z Xu, L Yu, Y Gao, F Liu, ... Nature Cell Biology, 1-13, 2024 | | 2024 |
| ElevatedNRASexpression as a potential driver of DCIS progression to basal-like invasive breast cancer Z Zheng, H Elsarraj, Y Hong, JT Lei, M Anurag, Y Shen, F Lo, L Feng, ... Cancer Research 82 (12_Supplement), 2979-2979, 2022 | | 2022 |
Xiang ZhangBaylor College of MedicineVerified email at bcm.edu
